Zakharova Natalia E, Batalov Artem I, Pogosbekian Eduard L, Chekhonin Ivan V, Goryaynov Sergey A, Bykanov Andrey E, Tyurina Anastasia N, Galstyan Suzanna A, Nikitin Pavel V, Fadeeva Lyudmila M, Usachev Dmitry Yu, Pronin Igor N
Federal State Autonomous Institution "N.N. Burdenko National Medical Research Center of Neurosurgery" of the Ministry of Health of the Russian, 4th Tverskaya-Yamskaya Str. 16, Moscow 125047, Russia.
Cancers (Basel). 2023 May 15;15(10):2760. doi: 10.3390/cancers15102760.
(1) Purpose: To determine the borders of malignant gliomas with diffusion kurtosis and perfusion MRI biomarkers. (2) Methods: In 50 high-grade glioma patients, diffusion kurtosis and pseudo-continuous arterial spin labeling (pCASL) cerebral blood flow (CBF) values were determined in contrast-enhancing area, in perifocal infiltrative edema zone, in the normal-appearing peritumoral white matter of the affected cerebral hemisphere, and in the unaffected contralateral hemisphere. Neuronavigation-guided biopsy was performed from all affected hemisphere regions. (3) Results: We showed significant differences between the DKI values in normal-appearing peritumoral white matter and unaffected contralateral hemisphere white matter. We also established significant ( < 0.05) correlations of DKI with Ki-67 labeling index and Bcl-2 expression activity in highly perfused enhancing tumor core and in perifocal infiltrative edema zone. CBF correlated with Ki-67 LI in highly perfused enhancing tumor core. One hundred percent of perifocal infiltrative edema tissue samples contained tumor cells. All glioblastoma samples expressed CD133. In the glioblastoma group, several normal-appearing white matter specimens were infiltrated by tumor cells and expressed CD133. (4) Conclusions: DKI parameters reveal changes in brain microstructure invisible on conventional MRI, e.g., possible infiltration of normal-appearing peritumoral white matter by glioma cells. Our results may be useful for plotting individual tumor invasion maps for brain glioma surgery or radiotherapy planning.
(1)目的:利用扩散峰度成像和灌注MRI生物标志物确定恶性胶质瘤的边界。(2)方法:对50例高级别胶质瘤患者,在增强区域、灶周浸润性水肿区、患侧大脑半球肿瘤周围外观正常的白质以及未受影响的对侧半球测定扩散峰度值和伪连续动脉自旋标记(pCASL)脑血流量(CBF)值。对所有患侧半球区域进行神经导航引导下活检。(3)结果:我们发现肿瘤周围外观正常的白质与未受影响的对侧半球白质的扩散峰度成像(DKI)值存在显著差异。我们还在高灌注增强肿瘤核心和灶周浸润性水肿区建立了DKI与Ki-67标记指数和Bcl-2表达活性的显著(<0.05)相关性。CBF与高灌注增强肿瘤核心中的Ki-67标记指数相关。100%的灶周浸润性水肿组织样本含有肿瘤细胞。所有胶质母细胞瘤样本均表达CD133。在胶质母细胞瘤组中,一些外观正常的白质标本被肿瘤细胞浸润并表达CD133。(4)结论:DKI参数揭示了传统MRI上不可见的脑微结构变化,例如肿瘤细胞可能浸润肿瘤周围外观正常的白质。我们的结果可能有助于绘制用于脑胶质瘤手术或放疗计划的个体肿瘤侵袭图谱。